δ-Tocotrienol, Isolated from Rice Bran, Exerts an Anti-Inflammatory Effect via MAPKs and PPARs Signaling Pathways in Lipopolysaccharide-Stimulated Macrophages

δ-Tocotrienol, an important component of vitamin E, has been reported to possess some physiological functions, such as anticancer and anti-inflammation, however their molecular mechanisms are not clear. In this study, δ-tocotrienol was isolated and purified from rice bran. The anti-inflammatory effect and mechanism of δ-tocotrienol against lipopolysaccharides (LPS) activated pro-inflammatory mediator expressions in RAW264.7 cells were investigated. Results showed that δ-tocotrienol significantly inhibited LPS-stimulated nitric oxide (NO) and proinflammatory cytokine (TNF-α, IFN-γ, IL-1β and IL-6) production and blocked the phosphorylation of c-Jun N-terminal kinase (JNK) and extracellular regulated protein kinases 1/2 (ERK1/2). δ-Tocotrienol repressed the transcriptional activations and translocations of nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1), which were closely related with downregulated cytokine expressions. Meanwhile, δ-tocotrienol also affected the PPAR signal pathway and exerted an anti-inflammatory effect. Taken together, our data showed that δ-tocotrienol inhibited inflammation via mitogen-activated protein kinase (MAPK) and peroxisome proliferator-activated receptor (PPAR) signalings in LPS-stimulated macrophages.


Introduction
Inflammation is a significant mechanism of the immune pathogenesis and against different harmful stimuli [1]. Inflammation may result in tissue injury, infection and stress or exposure to bacterial components, such as lipopolysaccharide (LPS) [2,3]. LPS is a component of the cell wall of gram-negative bacteria and was used to induce the cell inflammation model in macrophage RAW264.7. During inflammatory response, macrophages play an important role to provide a defense against the foreign stimuli. Macrophages take part in the inflammatory process through regulating a series of inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interferon-γ (INF-γ), interleukin-1β (IL-1β), IL-6 and IL-8 [4]. On the other hand, macrophages also stimulate the expressions and secretions

δ-Tocotrienol Downregulated the Expressions of Proinflammatory Factors
During suffering inflammatory disease, the proinflammatory factors, such as TNF-α, IL-1β, IL-6, and mediators of iNOS were always overproduced [27]. In our study, the mRNA expressions of proinflammatory factors were assessed by real-time quantitative PCR (RT-qPCR). The results indicated that the upregulation expressions of pro-inflammatory cytokine mRNAs in the LPS-stimulated group were significantly higher than that of the control group ( Figure 3A-D). δ-tocotrienol treatments decreased the mRNA expressions of TNF-α, IL-1β, IL-6 and iNOS in a dosage-dependant manner, as shown in Figure 3A-D. Western blotting further confirmed that δ-tocotrienol treatments (5 μM, 10 μM, 20 μM) inhibited the protein expression levels of TNF-α, IL-1β, IL-6 and iNOS in the LPS-stimulated macrophage ( Figure 4A-E). Taken together, δ-tocotrienol exerts an anti-inflammatory effect via decreasing expressions of inflammatory factors.

δ-Tocotrienol Downregulated the Expressions of Proinflammatory Factors
During suffering inflammatory disease, the proinflammatory factors, such as TNF-α, IL-1β, IL-6, and mediators of iNOS were always overproduced [27]. In our study, the mRNA expressions of proinflammatory factors were assessed by real-time quantitative PCR (RT-qPCR). The results indicated that the upregulation expressions of pro-inflammatory cytokine mRNAs in the LPS-stimulated group were significantly higher than that of the control group ( Figure 3A-D). δ-tocotrienol treatments decreased the mRNA expressions of TNF-α, IL-1β, IL-6 and iNOS in a dosage-dependant manner, as shown in Figure 3A

Effect of δ-Tocotrienol on MAPKs in LPS-Stimulated RAW264.7 Cells
It has been approved that mitogen-activated protein kinases (MAPKs) are phosphorylated in the inflammatory response, and that the MAPK transduction pathway activation is the key to signaling to regulate the expression of inflammatory cytokine [28,29]. To explore the anti-inflammatory mechanism of δ-tocotrienol, the phosphorylation situation of 3 subtypes of MAPKs, including c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase 1/2 (ERK1/2), and p38 were analyzed by Western blotting in the LPS-stimulated RAW264.7 cells. As shown in Figure 5A, LPS treatment caused an obvious increase of phosphorylation of ERK1/2, JNK and p38; Adding δ-tocotrienol resulted in a reduction of phosphorylation of ERK1/2, JNK (see Figure 5B,C), however δ-tocotrienol did not inhibit the phosphorylation of p38 (see Figure 5D) in a dosage-dependent manner. Our data showed that δ-tocotrienol that was treated with 20 µM was the effective dosage for the inhibition of ERK1/2 and JNK phosphorylation, and the protein contents of p-ERK1/2 and p-JNK were reduced to 76.6% and 28.9% ( Figure 5B,C), respectively. These results suggest that δ-tocotrienol exerts an anti-inflammatory effect which may be mediated by inhibiting the ERK/JNK activation (phosphorylation) in the LPS-stimulated cell inflammation model.

Effect of δ-Tocotrienol on MAPKs in LPS-stimulated RAW264.7 Cells
It has been approved that mitogen-activated protein kinases (MAPKs) are phosphorylated in the inflammatory response, and that the MAPK transduction pathway activation is the key to signaling to regulate the expression of inflammatory cytokine [28,29]. To explore the anti-inflammatory mechanism of δ-tocotrienol, the phosphorylation situation of 3 subtypes of MAPKs, including c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase 1/2 (ERK1/2), and p38 were analyzed by Western blotting in the LPS-stimulated RAW264.7 cells. As shown in Figure 5A, LPS treatment caused an obvious increase of phosphorylation of ERK1/2, JNK and p38; Adding δ-tocotrienol resulted in a reduction of phosphorylation of ERK1/2, JNK (see Figure 5B,C), however δ-tocotrienol did not inhibit the phosphorylation of p38 (see Figure 5D) in a dosage-dependent manner. Our data showed that δ-tocotrienol that was treated with 20 μM was the effective dosage for the inhibition of ERK1/2 and JNK phosphorylation, and the protein contents of p-ERK1/2 and p-JNK were reduced to 76.6% and 28.9% ( Figure 5B,C), respectively. These results suggest that δ-tocotrienol exerts an anti-inflammatory effect which may be mediated by inhibiting the ERK/JNK activation (phosphorylation) in the LPS-stimulated cell inflammation model.

Effect of δ-Tocotrienol on NF-κB /AP-1 Activities and Translocations
Transcription factors AP-1 and NF-κB are involved in many biological functions. In the inflammatory response, inflammatory cytokine, such as TNF-α, IFN-γ, IL-1β, IL-6 and iNOS have several AP-1 and NF-κB binding sites and the two transcript factors can directly bind the promoter of those genes to regulate inflammatory cytokine expressions [30,31]. After exposure to LPS alone, our data showed that the contents of p65 and c-Jun in the nuclei were increased significantly and LPS promoted the nuclear translocation of p65 and c-Jun ( Figure 6A,B). After treatments of different dosages of δ-tocotrienol, the contents of p65 and c-Jun in the nuclei were obviously reduced in a dose dependent manner compared with the LPS group and, in contrast, the contents of p65 and c-Jun in the cytoplasm were increased in RAW264.7 cells. Compared with the LPS group, the relative luciferase activities of NF-κB were reduced to 57.9%, 43.6% and 43.5% by reporter gene analysis ( Figure 6A,C), and the relative luciferase activities of AP-1 were reduced to 63.2%, 53.8% and 41.4% ( Figure 6B,D), respectively. This suggests that δ-tocotrienol may reduce inflammatory cytokine expressions via inhibiting NF-κB and AP-1 activation in the LPS-induced RAW264.7 cells. Furthermore, pNF-κB-Luc and pAP-1-Luc reporter genes were used to detect the effect of δ-tocotrienol on the transcriptional activities of NF-κB and AP-1. Consistent with the nuclear translocation data, luciferase reporter assays found that δ-tocotrienol significantly inhibited NF-κB and AP-1 activities in a dose-dependent manner, as shown in Figure 7A,B. MAPKs are found to be close with AP-1 and NF-κB activations [29,32]. Our results suggest that δ-tocotrienol may affect inflammatory cytokine expressions via MAPK/NF-κB and MAPK/AP-1 pathways.

Effect of δ-Tocotrienol on NF-κB /AP-1 Activities and Translocations
Transcription factors AP-1 and NF-κB are involved in many biological functions. In the inflammatory response, inflammatory cytokine, such as TNF-α, IFN-γ, IL-1β, IL-6 and iNOS have several AP-1 and NF-κB binding sites and the two transcript factors can directly bind the promoter of those genes to regulate inflammatory cytokine expressions [30,31]. After exposure to LPS alone, our data showed that the contents of p65 and c-Jun in the nuclei were increased significantly and LPS promoted the nuclear translocation of p65 and c-Jun ( Figure 6A,B). After treatments of different dosages of δ-tocotrienol, the contents of p65 and c-Jun in the nuclei were obviously reduced in a dose dependent manner compared with the LPS group and, in contrast, the contents of p65 and c-Jun in the cytoplasm were increased in RAW264.7 cells. Compared with the LPS group, the relative luciferase activities of NF-κB were reduced to 57.9%, 43.6% and 43.5% by reporter gene analysis ( Figure 6A,C), and the relative luciferase activities of AP-1 were reduced to 63.2%, 53.8% and 41.4% ( Figure 6B,D), respectively. This suggests that δ-tocotrienol may reduce inflammatory cytokine expressions via inhibiting NF-κB and AP-1 activation in the LPS-induced RAW264.7 cells. Furthermore, pNF-κB-Luc and pAP-1-Luc reporter genes were used to detect the effect of δ-tocotrienol on the transcriptional activities of NF-κB and AP-1. Consistent with the nuclear translocation data, luciferase reporter assays found that δ-tocotrienol significantly inhibited NF-κB and AP-1 activities in a dose-dependent manner, as shown in Figure 7A,B. MAPKs are found to be close with AP-1 and NF-κB activations [29,32]. Our results suggest that δ-tocotrienol may affect inflammatory cytokine expressions via MAPK/NF-κB and MAPK/AP-1 pathways.

Effect of δ-Tocotrienol on the Activities of PPARα and PPARγ In Vitro Models
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors which have three isoforms: PPARα, PPARβ/δ, PPARγ, and each isoform has its own physiological functions. PPARα was supposed to be involved in heart failure [33,34]. Both PPARα and PPARβ/δ have overlapping functions in cardiovascular diseases [34]. PPARγ is well known for its therapeutic potency of metabolic syndrome, type 2 diabetes and obesity [12,35,36]. In this study, we estimated the effect of δ-tocotrienol on the PPAR pathway in the LPS-stimulated RAW264.7 cells. The results revealed that in LPS-induced RAW264.7, δ-tocotrienol significantly inhibited the phosphorylation of PPARα at concentration of 5 μM, 10 μM, 20 μM in a dosage-dependent manner compared with the control group, as shown in Figure 8A,B. In this study, our data also demonstrated that δ-tocotrienol significantly depressed the phosphorylation of PPARγ at concentrations of 5 μM, 10 μM, 20 μM in a dosage-dependent manner compared with the control group.

Effect of δ-Tocotrienol on the Activities of PPARα and PPARγ In Vitro Models
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors which have three isoforms: PPARα, PPARβ/δ, PPARγ, and each isoform has its own physiological functions. PPARα was supposed to be involved in heart failure [33,34]. Both PPARα and PPARβ/δ have overlapping functions in cardiovascular diseases [34]. PPARγ is well known for its therapeutic potency of metabolic syndrome, type 2 diabetes and obesity [12,35,36]. In this study, we estimated the effect of δ-tocotrienol on the PPAR pathway in the LPS-stimulated RAW264.7 cells. The results revealed that in LPS-induced RAW264.7, δ-tocotrienol significantly inhibited the phosphorylation of PPARα at concentration of 5 µM, 10 µM, 20 µM in a dosage-dependent manner compared with the control group, as shown in Figure 8A,B. In this study, our data also demonstrated that δ-tocotrienol significantly depressed the phosphorylation of PPARγ at concentrations of 5 µM, 10 µM, 20 µM in a dosage-dependent manner compared with the control group.

Effect of δ-Tocotrienol on the Activities of PPARα and PPARγ In Vitro Models
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors which have three isoforms: PPARα, PPARβ/δ, PPARγ, and each isoform has its own physiological functions. PPARα was supposed to be involved in heart failure [33,34]. Both PPARα and PPARβ/δ have overlapping functions in cardiovascular diseases [34]. PPARγ is well known for its therapeutic potency of metabolic syndrome, type 2 diabetes and obesity [12,35,36]. In this study, we estimated the effect of δ-tocotrienol on the PPAR pathway in the LPS-stimulated RAW264.7 cells. The results revealed that in LPS-induced RAW264.7, δ-tocotrienol significantly inhibited the phosphorylation of PPARα at concentration of 5 μM, 10 μM, 20 μM in a dosage-dependent manner compared with the control group, as shown in Figure 8A,B. In this study, our data also demonstrated that δ-tocotrienol significantly depressed the phosphorylation of PPARγ at concentrations of 5 μM, 10 μM, 20 μM in a dosage-dependent manner compared with the control group.

Effect of δ-Tocotrienol on MAPKs and PPARs Signaling Models
To investigate whether the MAPK signaling pathway interacts with PPARs, which take part in the anti-inflammation of δ-tocotrienol, LPS-induced RAW264.7 cells were treated with the p38MAPK inhibitor SB203580, the JNK inhibitor SP600125 and the ERK1/2 inhibitor U0126. As shown in Figure 9A, in contrast to the δ-tocotrienol treated group, SB600125, U0126 and SP203580 treatment all suppressed the phosphorylation of PPARγ (Ser112) protein which was stimulated by LPS in the presence of δ-tocotrienol. Moreover, compared with the δ-tocotrienol treated group ( Figure 9B), both SP600125 and U0126 treatment inhibited the phosphorylated of PPARα (Ser384), while SB203580 treatment did not activate the phosphorylation of PPARα (Ser384) level. These data indicated that δ-tocotrienol inhibited PPARα activation via inhibiting JNK and ERK1/2 activities; δ-tocotrienol inhibited PPARγ phosphorylation through inhibiting p38, JNK and ERK1/2 activities.

Effect of δ-Tocotrienol on MAPKs and PPARs Signaling Models
To investigate whether the MAPK signaling pathway interacts with PPARs, which take part in the anti-inflammation of δ-tocotrienol, LPS-induced RAW264.7 cells were treated with the p38MAPK inhibitor SB203580, the JNK inhibitor SP600125 and the ERK1/2 inhibitor U0126. As shown in Figure 9A, in contrast to the δ-tocotrienol treated group, SB600125, U0126 and SP203580 treatment all suppressed the phosphorylation of PPARγ (Ser112) protein which was stimulated by LPS in the presence of δ-tocotrienol. Moreover, compared with the δ-tocotrienol treated group ( Figure 9B), both SP600125 and U0126 treatment inhibited the phosphorylated of PPARα (Ser384), while SB203580 treatment did not activate the phosphorylation of PPARα (Ser384) level. These data indicated that δ-tocotrienol inhibited PPARα activation via inhibiting JNK and ERK1/2 activities; δ-tocotrienol inhibited PPARγ phosphorylation through inhibiting p38, JNK and ERK1/2 activities.

Discussion
In the present study, we demonstrated the anti-inflammatory effects and molecular mechanisms of δ-tocotrienol through the MAPKs/AP-1 and PPARs/AP-1 pathways. In previous studies, it is reported that δ-tocotrienol depressed the expressions of proinflammatory genes, however the role of δ-tocotrienol in the MAPK/AP-1 and PPARs/AP-1 pathways and the interactions between these two pathways remains unclear [15]. Our results verified that δ-tocotrienol significantly depressed the productions of IL-1β, IL-6, iNOS and TNF-α, meanwhile it does not have cytotoxicity on LPS-induced RAW264.7, as confirmed by MTS assay.
Rice bran oil and rice germ oil, together with palm oil have been used traditionally as cooking oil which have a high content of tocotrienol [37]. Recent studies showed that vitamin E components, like tocotrienol-rich fraction, had already been used as dietary complements to prevent breast cancer

Discussion
In the present study, we demonstrated the anti-inflammatory effects and molecular mechanisms of δ-tocotrienol through the MAPKs/AP-1 and PPARs/AP-1 pathways. In previous studies, it is reported that δ-tocotrienol depressed the expressions of proinflammatory genes, however the role of δ-tocotrienol in the MAPK/AP-1 and PPARs/AP-1 pathways and the interactions between these two pathways remains unclear [15]. Our results verified that δ-tocotrienol significantly depressed the productions of IL-1β, IL-6, iNOS and TNF-α, meanwhile it does not have cytotoxicity on LPS-induced RAW264.7, as confirmed by MTS assay.
Rice bran oil and rice germ oil, together with palm oil have been used traditionally as cooking oil which have a high content of tocotrienol [37]. Recent studies showed that vitamin E components, like tocotrienol-rich fraction, had already been used as dietary complements to prevent breast cancer and hypercholesterolemia and its anti-inflammatory activity is the greatest compared with that of a-tocopherol and a-tocopheryl acetate [38][39][40]. Vitamin E components, such as γ-tocopherol, δ-tocopherol and γ-tocotrienol, have specific anti-inflammatory and antioxidant effects which are superior to those of α-tocopherol [41]. Several studies have shown that γ-tocotrienol inhibited LPS-stimulated RAW264.7 macrophages and IL-1β-activated lung epithelial cells through NF-κB and JAK-STAT6 or JAK-STAT3 signaling pathways [42,43]. In human endothelial cells, δ-tocotrienol is the most potent isomer of tocotrienols in depressing the expression of IL-6, ICAM-1, VCAM-1 and NF-κB compared with that of α-, β-, γ-tocotrienol [35]. δ-Tocotrienol has several potential health benefits, such as prevention of certain types of cancer [44], heart diseases and other acute or chronic inflammations. Among the isoforms of tocotrienols, the antioxidant and anti-inflammation functions of γ-tocotrienol were well studied, and only few experiments showed that δ-tocotrienol can decrease the expression of inflammatory factors in macrophages, however its molecular mechanism is unknown.
In the present study, we demonstrated the anti-inflammatory effects and molecular mechanisms of δ-tocotrienol through the MAPKs/AP-1 and PPARs/AP-1 pathways. In previous studies, it is reported that δ-tocotrienol depressed the expressions of proinflammatory genes, however the role of δ-tocotrienol in the MAPK/AP-1 and PPARs/AP-1 pathways and the interactions between these two pathways remains unclear [15]. Our results verified that δ-tocotrienol significantly depressed the productions of IL-1β, IL-6, iNOS and TNF-α, meanwhile it does not have cytotoxicity on LPS-induced RAW264.7, as confirmed by MTS assay.
MAPKs signaling pathway and PPARs signaling pathway were supposed to take part in the occurrence of inflammation. Although the cellular signaling pathways and molecular mechanisms of inflammation activation are very complicated, mitogen-activated protein kinase (MAPK) is a key signaling pathway in the initiation and development of the inflammation process. MAPK can transmit the extracellular information into cytoplasm and nucleus in the end. These serine/threonine kinases include extracellular signal-regulated kinase 1/2 (ERK1/2), extracellular signal-regulated kinase 5 (ERK5) c-Jun NH2-terminal kinase (JNK) and p38 and finally to the NF-κB and AP-1 in cell nucleus. Among PPAR receptors, PPARα was the first to be identified and expressed mainly in liver, heart, kidney and adipose tissues [15,45]. PPARα upregulates the expression of IκB, which inhibits the activation and nuclear translocation of the proinflammatory transcription factor NF-κB [46]. Both PPARα and PPARγ are reported to reduce the NF-κB transcriptional activity [13]. Fatty acids and their derivatives can activate peroxisome proliferator-activated receptors (PPARs) which regulate the expression of signaling pathways genes that are involved in adipogenesis, lipid metabolism, inflammation, type 2 diabetes and the maintenance of metabolic homeostasis [47]. In this study, δ-tocotrienol was found to decrease the production of inflammatory cytokines, such as IL-6, IL-1β and TNF-α with iNOS. Meanwhile in PPARα knock-out young (4-week-old) and senescent mice (42-week old), it was reported that δ-tocotrienol can also decrease the mRNA expressions of IL-6, IL-1β and TNF-α in vivo. However, the mediation of δ-tocotrienol via PPARs and MAPKs signaling is still unclear. In our present study, we found that δ-tocotrienol inhibits inflammation by activation of both PPARα and PPARγ receptors. Indeed, overweight and obesity inflammation are related to the interaction of nutrition, the immune system and metabolic organs [48][49][50]. In low grade chronic inflammation, where the innate immune system and arteries, heart, and brain are involved, all the three PPAR isotypes showed anti-inflammatory effects [31,45]. Both PPARα and PPARγ are reported to reduce the NF-κB transcriptional activity [13].
In our present study, we found that δ-tocotrienol inhibited MAPKs activation and downregulated the expression of inflammatory cytokines as IL-1β, IL-6, TNF-α and iNOS in the LPS-stimulated cell inflammation model. For all of those cytokines, they have AP-1 and NF-κB binding sites in the promoters of those genes. c-Jun is a direct target of JNK, and JNK activation will result in AP-1 activation, which promotes the expressions of proinflammatory factors. Our study also confirmed that δ-tocotrienol can inhibit the phosphorylation of JNK and transcriptional activity of AP-1. This means that δ-tocotrienol can inhibit expressions of proinflammatory factors via downregulating JNK (MAPK). δ-tocotrienol inhibited activation ERK1/2 and transcriptional activity of NF-κB, and δ-tocotrienol decreased expressions of proinflammatory factors through ERK1/2/NF-κB, which belonged to another important pathway. The results suggest that both JNK (MAPK) and ERK1/2/NF-κB were involved in the inhibition of the activation of MAPKs. Meanwhile, the effect of δ-tocotrienol on PPARs signaling in LPS activated RAW264.7 cells was estimated by Western blotting. The results demonstrated that the treatment of δ-tocotrienol suppressed the phosphorylation of PPARα and PPARγ and the two different isotypes in LPS that induced murine macrophages in a dosage dependent way. It was found that PPARα and PPARγ can repress the inflammatory response by blocking the activation of NF-κB [51,52]. NF-κB was formed by p65 and p50 proteins, and the phosphorylation of translocation of NF-κB from cytoplasm to nucleus leads to overexpressions of proinflammatory factors [53]. Moreover, when MAPK inhibitors were added to δ-tocotrienol treated RAW264.7 cells, the phosphorylation of PPARγ was further downregulated. On the other hand, both JNK and ERK1/2 inhibitors treatment blocked the phosphorylation of PPARα (Ser384), while p38 inhibitor treated had a weak effect on the phosphorylation of PPARα (Ser384) level. The results indicated that δ-tocotrienol upregulated the phosphorylation of PPARα through JNK and ERK1/2 and upregulated the phosphorylation of PPARγ by JNK and ERK1/2.
In conclusion, it is well known that MAPKs signaling play a key role in inflammation; we demonstrated that δ-tocotrienol repressed the inflammatory response via the inhibition of MAPK/ERK/JNK activation. PPARs are always the target of many drugs which are therapy to metabolic syndrome, dyslipidemia, insulin resistance, hypertension, type 2 diabetes and cardiovascular diseases. This is the first study to report the fact that δ-tocotrienol reduces AP-1 activation during LPS-stimulated inflammatory response, and δ-tocotrienol inhibits inflammatory cytokine expressions via MAPK and PPARs signalings. Further investigation found that crosstalk exists between MAPKs and PPARs, which is involved in the anti-inflammatory effect of δ-tocotrienol. δ-tocotrienol can be developed as a food supplement for diseases like obesity, cardiovascular diseases, diabetes, hypertension and hyperlipidemia, which are closely related to inflammation and chronic low-grade inflammation which MAPKs and PPARs signaling pathways are involved in.

Isolation of Rice Bran Oil by Supercritical Carbon Dioxide Extraction
The bran was dried using a commercial dryer (STERIS, Worcester, MA, USA) for 3 min at 110 • C in a vacuum sealed plastic pouch and was stored at −20 • C for further use. Each rice bran sample of 100 g was accurately weighed through analytical balance and was loaded into a 200 mL high-pressure vessel equipped with a water jacket (HanYang Sci., Seoul, Korea). The CO 2 flow rate was routinely kept constant at 2.5 L/min. In every experimental design, the extracted oil was weighed with an analytical balance at set time intervals. Supercritical CO 2 extraction was carried out using HA 221-50-06-C (Huaan Company Ltd., Nantong, China). Pure CO 2 was applied by using a high pressure pump 2TB-50 (Huaan Company Ltd., Nantong, China). According to Yoon [29], the extraction temperature was set at 60 • C, and the extraction pressure was set at 27.6 MPa for 60 min. The SC-CO 2 extraction experiments at each specific combination of pressure and temperature were performed in triplicate.

High Performance Liquid Chromatography (HPLC)
The rice bran oil extracts were dissolved in methanol, were further filtered with a 0.45 µm filter and were analyzed by HPLC. δ-Tocotrienol standard sample was purchased from Sigma (Sigma Co., Ltd., St. Louis, MO, USA). HPLC analysis was performed on a Shimadzu Prominence series apparatus with a fluorescence detector (Prominence RF-20A/Axs, Shimadzu Co., Ltd., Kyoto, Japan). The excitation wavelength was 296 nm and the emission wavelength was 325 nm, which were operated on fluorescence detector. The Hypersil Gold PFP column (250 mm × 4.6 mm i.d., 5 µm, ThermoFisher Scientific, Waltham, MA, USA) was used as an analytical column. The eluents were methanol/H 2 O (85:15, vol/vol) at a flow rate of 0.8 mL/min. All the results were recorded, and the peaks were integrated by the chromatography software Labsolution LC (Shimadzu, Kyoto, Japan). δ-Tocotrienol was purified by Shim-pack PREP-ODS (20.0 mm × 250 mm, 15 µm, Shimadzu, Kyoto, Japan). The eluents include acetonitrile, tetrahydrofuran, methanol, 1% ammonium acetate (684:220:68:28) and the flow rate was 8 mL/min. The δ-tocotrienol standard that was purchased from Chromadex, Inc. (Irvine, CA, USA) was used to determine the absorption peak of δ-tocotrienol.

Cell Culture
RAW264.7 is a mouse monocyte-macrophage cell line and was purchased from the Institute of Cell Biology, Chinese Academy of Science, Shanghai, China. RAW264.7 cells were cultured in RPMI 1640 medium that was supplemented with 10% FBS (Gibco-BRL, Carlsbad, CA, USA) at 37 • C in a humidified incubator with 5% CO 2 atmosphere. The experiment details were described in our recent publication [32]. δ-Tocotrienol that was extracted from rice bran was dissolved in ethanol.

Cell Viability Assay
Cell viability was evaluated by the CellTiter 96 Aqueous One Solution Proliferation Assay Kit (Promega). The treated cells were incubated for 24 h, and then growth medium was replaced by a solution of 100 µL of fresh growth medium and 20 µL of MTS. The plate was incubated for another 2 h at 37 • C and the absorbance was measured at 490 nm. The percentage of cell viability relative to ethanol (solvent control) was calculated.

Observation of Morphological Changes
The morphological change of murine macrophages RAW264.7 is considered one of the remarkable characteristics of the toxicological effect. To determine whether δ-tocotrienol was toxicant to RAW264.7 cells, an optical microscopy (DM2500, Leica, Solms, Germany) was used to detect the toxicity of δ-tocotrienol and was compared with the control group. After 72 h of δ-tocotrienol (0 µM, 5 µM, 10 µM, 20 µM, 40 µM, 80 µM) treatment on RAW264.7 cells, the morphological changes, including cell floating and shrinkage and nucleic blebbing, were observed.

RNA Isolation and RT-qPCR
Total RNA from murine macrophages RAW 264.7 cells was extracted by the Trizol reagent kit (Transgen, Beijing, China) and was then reverse transcribed by using high-Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Foster City, CA, USA). Consistent with Liu et al. [28] and Guo et al. [32], the relative mRNA expression levels of pro-inflammatory factors and iNOS were analyzed by real-time quantitative PCR (RT-qPCR). Cells were treated with δ-tocotrienol (5 µM, 10 µM, 20 µM) for 2 h followed by adding LPS (1 µg/mL) for 6 h. According to the manufacturer's protocol, 1 µg total RNA extracted from RAW264.7 cells was used in reverse transcription reaction with the One Step RT-PCR kit (Gibco-BRL). PCR amplifications were carried out for 32 cycles and each cycle consisted of a denaturing step for 3 min at 94 • C, a further denaturing at 94 • C for 30 s, an annealing step for 30 s at 60 • C and a polymerization step for 1 min at 72 • C. The PCR primer was according to Guo's publication [32].

Extraction of Nuclear and Cytosolic Proteins
RAW264.7 cells were cultured in a 100 mm dish at a density of 1 × 10 6 cells/mL for 24 h. After incubation, the cells were treated with various concentrations of δ-tocotrienol (0.5 µM, 10 µM and 20 µM) for 2 h and 1 µg/mL of LPS was then added for 60 min. Total protein from the cells was extracted with radio immunoprecipitation assay (RIPA) buffer (2 mM PMSF, 2 mM EDTA and 2 mM orthovanadate, 1% Triton X-100, 0.5% SDS, 0.1% deoxycholate) that was supplemented with a cocktail of protease and phosphatase inhibitors. RAW264.7 cells were harvested, and nuclear and cytosolic fractions were prepared using a Nuclear Extraction Kit (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer's instructions.

Statistical Analysis
For statistical analysis, SPSS17.0 software (Chicago, IL, USA) was employed. One-way ANOVA or student's t-test was used for determining the statistically significant differences between the values of various experimental and control groups. Data was expressed as means ± SD, and a p value of 0.05 was considered statistically significant and of 0.01 was considered statistically very significant.